GHO-backed Envision Pharma Group buys Excellere’s Two Labs

GHO recently boosted its stake in Envision – providing an exit for Ardian – in a transaction anticipated to value the pharma medical affairs business at $750m-plus, sources said in September.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this